Latest MissionIR Articles

MissionIRNewsBreaks – Pelican Acquisition Corp. (NASDAQ: PELI) Approves Business Combination With Greenland Exploration And Pelican Holdco

March 20, 2026 9:50am

Pelican Acquisition (NASDAQ: PELI) announced that shareholders approved its proposed business combination with Pelican Holdco Inc., Greenland Exploration Limited and March GL Company at an extraordinary general meeting held March 19, 2026, with closing of the transaction expected on or about March 24, 2026. The deal is intended to form a publicly traded energy company […]

Read Article

MissionIRNewsBreaks – Black Hawk Acquisition Corporation (Nasdaq: BKHA) SPAC Target Vesicor Therapeutics Names Michael Tolentino CEO

March 20, 2026 9:00am

Black Hawk Acquisition (Nasdaq: BKHA, BKHAU, BKHAR) announced that its proposed de-SPAC acquisition target, Vesicor Therapeutics Inc., has appointed Michael Tolentino, M.D., as chief executive officer effective March 17, 2026, succeeding founder Luo Feng, Ph.D., who will transition to chief scientific officer as the company advances its p53-based cancer therapeutic platform and prepares for IND-enabling studies and a […]

Read Article

MissionIRNewsBreaks – ParaZero Technologies Ltd. (NASDAQ: PRZO) Signs Strategic Cooperation Agreement With BonV Aero To Expand Counter-UAS Presence In India

March 20, 2026 8:40am

ParaZero Technologies (NASDAQ: PRZO) announced the signing of a strategic cooperation agreement with India-based BonV Aero to market its portfolio of counter-UAS solutions, led by the DefendAir system, a mobile, net-based interception platform designed for rapid deployment against hostile drones, while also enabling future configurations and integrations. The companies have already conducted a live demonstration […]

Read Article

MissionIRNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) Highlights HyBryte Clinical Data In Peer-Reviewed Journal Publication

March 19, 2026 9:45am

Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company focused on rare diseases, announced that a comprehensive summary of clinical trials evaluating HyBryte(TM) (synthetic hypericin) for cutaneous T-cell lymphoma has been published in the peer-reviewed journal Expert Opinion on Investigational Drugs, highlighting the therapy’s safety profile, non-mutagenic mechanism and demonstrated efficacy across studies, while supporting its potential as a first-line treatment […]

Read Article

MissionIRNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) Featured On BioMedWire Podcast Highlighting Phase 3 HyBryte Progress And Key Inflection Points

March 19, 2026 9:33am

Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company focused on rare diseases, was featured in the latest BioMedWire Podcast episode where CEO Christopher Schaber discussed the upcoming interim analysis of the Phase 3 FLASH2 study evaluating HyBryte(TM) for cutaneous T-cell lymphoma, noting strong blinded aggregate response rates above initial assumptions and outlining potential outcomes including early study completion or continued enrollment, while […]

Read Article

Navigating a Rapidly Evolving Technology Landscape: Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ) and the Trump Administration’s Push to Secure Domestic Supplies of Critical Minerals

March 19, 2026 9:30am

Disseminated on behalf of Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ) and may include paid advertising. As geopolitical tensions reshape global supply chains, critical minerals have become integral to economic and national security. Trilogy Metals (NYSE American: TMQ) (TSX: TMQ) is becoming increasingly aligned with this shift, as the U.S. Administration ramps up efforts to counter foreign dominance, […]

Read Article

MissionIRNewsBreaks – Forward Industries, Inc. (NASDAQ: FWDI) Repurchases Shares In $27.4M Transaction To Increase SOL-Per-Share

March 19, 2026 8:40am

Forward Industries (NASDAQ: FWDI), the leading Solana treasury company, announced it has entered into a privately negotiated agreement to repurchase 6,164,324 shares for $27.4 million, reducing shares outstanding and increasing SOL-per-share to 0.0662 following the transaction, which is being financed through a $40 million digital currency loan agreement with Galaxy Digital secured by treasury assets […]

Read Article

MissionIRNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Signs Definitive Agreement To Acquire NYIAX, Expanding Institutional-Grade Exchange Infrastructure

March 19, 2026 8:00am

Datavault AI (NASDAQ: DVLT), a provider of data monetization, credentialing, digital engagement and real-world asset tokenization technologies, announced it has signed a definitive agreement to acquire NYIAX Inc., adding NYIAX’s intellectual property portfolio and blockchain-powered trading platform to support Datavault AI’s planned rollout of specialized exchanges, including its Information Data Exchange(R), while combining AI-driven valuation, […]

Read Article

MissionIRNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Secures Costa Rica Approval for Kinesiology Tape Line 

March 18, 2026 9:50am

Nutriband (NASDAQ: NTRB) announced that the Costa Rica Ministry of Health has approved its line of kinesiology tapes for import and sale, with exclusive distribution partner Innomedica CCB overseeing and financing the regulatory process. The company plans to ramp up marketing efforts in partnership with Innomedica, targeting both its kinesiology tape products and mosquito repellent patch line following the […]

Read Article

Beeline Holdings Inc. (NASDAQ: BLNE) Partners with TYTL Corp on Tokenized Fractional Real Estate Model

March 18, 2026 9:30am

Beeline Holdings (NASDAQ: BLNE),  a fast-growing digital mortgage platform redefining the path to homeownership, recently announced a collaboration with TYTL Corp., a company developing a blockchain-enabled system that tokenizes deed-recorded equity interests in residential real estate. Under the agreement, Beeline will support fractional equity acquisitions through its BeelineEquity platform while its subsidiary, Beeline Title, will […]

Read Article

Soligenix Inc. (NASDAQ: SNGX) Advances Rare Disease Innovation Through Platform Science and Expanding Therapeutic Pipeline

March 18, 2026 8:00am

Medical progress has transformed the treatment of many common illnesses, yet thousands of rare diseases still lack effective therapies. Companies working at the intersection of biotechnology innovation and rare disease research are increasingly focused on addressing these gaps, including Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company developing and commercializing therapies and vaccines for rare diseases […]

Read Article

MissionIRNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Receives FDA Feedback On Bioequivalence For Ketamine Product 

March 17, 2026 10:40am

NRx Pharmaceuticals (NASDAQ: NRXP) announced it received a letter from the FDA’s Bioequivalence Program stating no bioequivalence deficiencies were identified at this time in its Abbreviated New Drug Application, with a preliminary determination ahead of anticipated approval in Summer 2026. The company highlighted its preservative-free ketamine formulation, which excludes benzethonium chloride, as a potential advancement in safety and stability, while continuing to pursue […]

Read Article

MissionIRNewsBreaks – Safe Pro Group Inc. (NASDAQ: SPAI) Completes Participation In U.S. Army TiC 2.0 Autonomous Breach Event 

March 17, 2026 9:07am

Safe Pro Group (NASDAQ: SPAI) announced it has completed participation in the U.S. Army Transforming in Contact (TiC) 2.0 Autonomous Breach event, where its patented AI tools were deployed in real-world operational environments by soldiers and command personnel during a two-week exercise at Fort Hood, Texas. The company’s SPOTD platform and NODE system were used to identify threats, […]

Read Article

Safe Pro Group Inc. (NASDAQ: SPAI) Completes Delivery of AI Edge Processing System to the U.S. Government, and Announces a Drone Inspection Contract with a Multinational Telecommunications Firm

March 17, 2026 8:00am

Safe Pro Group (NASDAQ: SPAI), a tech company that delivers security and defense solutions, recently announced that it has completed the full delivery of the company’s AI-powered edge processing systems valued at $1 million to the U.S. Government (https://ibn.fm/hNZEA). Safe Pro Group’s AI-powered edge processing systems are tactical, hardware-based units able to analyze drone imagery […]

Read Article

MissionIRNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Schedules Q4 And Full-Year 2025 Financial Results Release

March 17, 2026 8:00am

Datavault AI (NASDAQ: DVLT) announced it will report financial results for the fourth quarter and full year 2025 prior to market open on March 19, 2026, followed by a conference call and live webcast at 8:30 a.m. ET the same day. CEO Nathaniel Bradley and CFO Brett Moyer will host the presentation, with dial-in access […]

Read Article

MissionIRNewsBreaks – Innovation Beverage Group Limited (NASDAQ: IBG) Closes $6 Million Public Offering 

March 16, 2026 2:33pm

Innovation Beverage Group (NASDAQ: IBG) announced the closing of a registered public offering that generated approximately $6 million in gross proceeds before fees and expenses. The offering consisted of 3,428,569 common units or pre-funded units, each including one ordinary share or pre-funded warrant along with Series A and Series B warrants to purchase additional ordinary shares at an exercise price of $1.75 per share. […]

Read Article

MissionIRNewsBreaks – Wearable Devices Ltd. (NASDAQ: WLDS) Expands AI Advisory Board To Support ai6 Labs Growth

March 16, 2026 9:54am

Wearable Devices (NASDAQ: WLDS) announced a significant expansion of its AI expert advisory board to support the advancement of its ai6 Labs initiative, which is focused on neural AI innovation powered by non-invasive electromyography technology and the company’s Mudra platform. The company said the expanded advisory leadership includes Leor Stern as Senior AI Advisor for strategic growth alongside existing […]

Read Article

Investing in Innovation: Evaluating the Clinical and Commercial Potential of LB-100 and Liora’s Proton Therapy

March 16, 2026 8:45am

LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT), a clinical-stage pharmaceutical company, and the company’s subsidiary, Liora Technologies, both develop cancer therapies that, when combined, have the potential to improve outcomes and results for cancer patients. LIXTE’s flagship product and lead clinical candidate is LB-100, which is a proprietary small-molecule inhibitor of protein phosphatase 2A (“PP2A”). Designed […]

Read Article